Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction: For the DANAMI-2 investigators

Cardiology

Volumn 113, Issue 1, 2009, Pages 72-80

  Busk, Martin ^a   Kristensen, Steen D ^a   Rasmussen, Klaus ^a   Kelbaek, Henning ^b   Thayssen, Per ^c   Madsen, Jan K ^d   Abildgaard, Ulrik ^d   Krusell, Lars R ^a   Mortensen, Leif S ^e   Thuesen, Leif ^a   Andersen, Henning R ^a   Nielsen, Torsten T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e UNI C   (Denmark)

Author keywords

Angioplasty; Myocardial infarction; Reinfarction; Thrombolytic therapy; Time factor

Indexed keywords

ALTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; EVALUATION; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HAZARD ASSESSMENT; HEART DEATH; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION;

AGED; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 55749105518     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000171069     Document Type: Article

References (28)

1. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS: A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733-742.
2. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673-679.
3. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H: A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-684.
4. Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink AT, Hoorntje JC, Ottervanger JP, Suryapranata H: Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location. Heart 2006; 92: 75-79.
5. Welty FK, Mittleman MA, Lewis SM, Healy RW, Shubrooks SJ Jr, Muller JE: Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol 1995; 76: 431-435.
6. Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS, Thuesen L, Kristensen SD, Nielsen TT, Andersen HR: The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J 2008;29:1259-1266.
7. Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, Pedersen F, Mortensen LS: Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction- 2 (DANAMI-2). Am Heart J 2003; 146: 234-241.
8. Vejlstrup N, Clemmensen P, Steinmetz E, Krusell LR, Hansen KN, Christiansen I, Hansen PR, Andersen HR: Blinded end point adjudication in the 'Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction' (DANAMI-2 trial). Heart Drug 2003; 3: 127-133.
9. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson A, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez- Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, Mc- Gregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez- Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N: Universal definition of myocardial infarction. Circulation 2007; 116: 2634- 2653.
10. Widimsky P, Bilkova D, Penicka M, Novak M, Lanikova M, Porizka V, Groch L, Zelizko M, Budesinsky T, Aschermann M: Longterm outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial. Eur Heart J 2007; 28: 679-684.
11. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, van 't Hof AW, Suryapranata H: Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-1419.
12. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE: Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
13. Kerr AJ, Stewart RA, Low CJ, Restieaux NJ, Wilkins GT: Long stenting in native coronary arteries: relation between vessel size and outcome. Cathet Cardiovasc Diagn 1998; 44: 170-174.
14. Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS, Holmes DR, Berger PB: Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol 2002; 40: 1567-1572.
15. Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KK: Beyond restenosis: five-year clinical outcomes from secondgeneration coronary stent trials. Circulation 2004; 110: 1226-1230.
16. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS: Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2005; 111: 369-376.
17. Witt BJ, Jacobsen SJ, Weston SA, Killian JM, Meverden RA, Allison TG, Reeder GS, Roger VL: Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 2004; 44: 988-996.
18. Sejersten M, Maynard C, Clemmensen P: Effects of abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI-2 trial). Acute Card Care 2006; 8: 75-82.
19. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Van de Werf F, Antman EM, Topol EJ: Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005; 293: 1759-1765.
20. De Luca G, Ernst N, van 't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Suryapranata H: Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 2006; 151: 1256-1259.
21. Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, Yerkey MW, O'Neill W, Grines CL: The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003; 42: 1173-1177.
22. Orn S, Cleland JG, Romo M, Kjekshus J, Dickstein K: Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. Am J Med2005; 118: 752-758.
23. Boersma E: Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary interventionand in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27: 779-788.
24. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533.
25. Sabatine MS, Cannon CP, Gibson CM, Lopez- Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, Mc- Cabe CH, Braunwald E: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005; 352: 1179-1189.
26. ASSENT-3 Investigators: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001; 358: 605-613.
27. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
28. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, Foody JM, Krumholz HM, Phillips CO, Kashani A, You JJ, Tu JV, Ko DT: Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007; 49: 422-430.